CoChat

Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer’s disease

Open access
Ager, Rahasson R., Fonseca, Maria I., Chu, Shu‐Hui, Sanderson, Sam D., Taylor, Stephen M., Woodruff, Trent M., Tenner, Andrea J. · 2010 · Journal of Neurochemistry
Cited by 86

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

J. Neurochem. (2010) 113, 389–401. Alzheimer’s disease (AD), a progressive neurodegenerative disease characterized by the accumulation of amyloid‐β protein and neuronal loss, is the leading cause of age‐related dementia in the world today. The disease is also associated with neuroinflammation, robust activation of astrocytes and microglia, and evidence of activation of the complement system, localized with both fibrillar amyloid‐β (fAβ) plaques and tangles. The observations are consistent with a complement‐dependent component of AD progression. We have previously shown that inhibition of the major complement receptor for C5a (CD88) with the antagonist PMX205 results in a significant reduction in pathology in two mouse models of AD. To further characterize the role of complement in AD‐related neuroinflammation, we examined the age‐ and disease‐associated expression of CD88 in brain of transgenic mouse models of AD and the influence of PMX205 on the presence of various complement activation products using flow cytometry, western blot, and immunohistochemistry. CD88 was found to be up‐regulated in microglia, in the immediate vicinity of amyloid plaques. While thioflavine plaque load and glial recruitment is significantly reduced after treatment with PMX205, C1q remains co‐localized with fAβ plaques and C3 is still expressed by the recruited astrocytes. Thus, with PMX205, potentially beneficial activities of these early complement components may remain intact, while detrimental activities resulting from C5a–CD88 interaction are inhibited. This further supports the targeted inhibition of specific complement mediated activities as an approach for AD therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2010.06595.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 86

Metadata

Authors
Ager, R. R., Fonseca, M. I., Chu, S., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., & Tenner, A. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2010-03-16
Volume
113
Issue
2
Pages
389-401
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1979958331
Cited by
86
References
9
FWCI
3.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1471-4159.2010.06595.x
The paper
Ager, R. R., Fonseca, M. I., Chu, S., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2010). Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer’s disease. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2010.06595.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.